Kamis, 27 Maret 2008

A VIDEO ABOUT SINGULAIR FOR ASTHMA AND AN FDA REPORT OF POSSIBLE PROBLEMS WITH SINGULAIR MONTELUKAST FOR ASTHMA

A VIDEO ABOUT SINGULAIR FOR ASTHMA AND AN FDA REPORT OF POSSIBLE PROBLEMS WITH SINGULAIR MONTELUKAST FOR ASTHMA



The FDA is reported to be investigating possible adverse effects in the popular asthma drug called Singulair or montelukast. Singulair belongs to the asthma drugs called leukotriene inhibitors and is designed to decrease problems with asthma by blocking leukotrienes which are body chemicals causing inflammation. Asthma is inflammation of the airways. People with asthma have hypersensitive airways. The airways are the tubes that carry the air into the lungs. In asthma the airways narrow, become inflamed. So people with asthma hear wheezing noises. Singulair works to lower that inflammation. It is one of the medications along with medicines like albuterol and inhaled steroids that doctors use to control asthma. "The FDA said it is reviewing post-marketing reports it has received of behavior and mood changes, suicidal thoughts and behaviors as well as actual suicides in patients who took Singulair and has asked Merck to look at its own database".


















Watch a video about Singulair How it works Click the arrow to start





  • FDA Studies Whether Singulair Is Linked to Mood, Suicide Issues
  • Tidak ada komentar:

    Posting Komentar